Which bit of All and Trials don't Roche understand?

Drug firm Roche pledges greater access to trials data 26 February 2013 Last updated at 18:00 Research suggests half of all clinical trials have never been published The pharmaceutical company Roche has announced that it will make more of the data from its clinical trials available to researchers. The company says it will appoint a panel of experts to evaluate and approve requests to access anonymised patient data. We understand and support calls for our industry to be more transparent” Daniel O'Day Roche But the announcement has been dismissed as "pathetic" by campaigners arguing for greater transparency from the pharmaceutical industry - an issue I wrote about last month. It's estimated that half of all clinical trials have never been published and positive trial results are twice as likely to be published as negative findings. The AllTrials campaign wants the pharmaceutical industry to publish all data, and is supported by the Wellcome Trust, the BMJ and NICE. "More transparent" Roche, which makes the anti-viral medicine Tamiflu, has been repeatedly criticised by researchers for failing to grant access to all its data on the drug. In response Roche has appointed a four man panel headed by flu expert Prof Albert Osterhaus to look at data on Tamiflu which the company says will "identify unanswered questions". Roche says it will also appoint an "independent body" to assess the validity of requests for unpublished trial data for its other medicines. Daniel O'Day, Ch...
Source: PharmaGossip - Category: Pharma Commentators Authors: Source Type: blogs